ASPECT BIOSYSTEMS
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
ASPECT BIOSYSTEMS
Industry:
Biotechnology Life Science
Founded:
2013-11-19
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.aspectbiosystems.com
Total Employee:
51+
Status:
Active
Contact:
604-263-0502
Email Addresses:
[email protected]
Total Funding:
81.07 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Government of British Columbia
Government of British Columbia investment in Grant - Aspect Biosystems
Government of Canada
Government of Canada investment in Grant - Aspect Biosystems
Novo Nordisk
Novo Nordisk investment in Convertible Note - Aspect Biosystems
Pacific Economic Development Canada
Pacific Economic Development Canada investment in Grant - Aspect Biosystems
Page One Ventures
Page One Ventures investment in Venture Round - Aspect Biosystems
Stem Cell Network (SCN)
Stem Cell Network (SCN) investment in Grant - Aspect Biosystems
Innovate BC
Innovate BC investment in Grant - Aspect Biosystems
Pallasite Ventures
Pallasite Ventures investment in Series A - Aspect Biosystems
Rhino Ventures
Rhino Ventures investment in Series A - Aspect Biosystems
Radical Ventures
Radical Ventures investment in Series A - Aspect Biosystems
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-21 | Aspect Biosystems Appoints Eric Roos as Chief Business Development Officer |
Official Site Inspections
http://www.aspectbiosystems.com Semrush global rank: 4.16 M Semrush visits lastest month: 2.46 K
- Host name: ec2-35-183-91-107.ca-central-1.compute.amazonaws.com
- IP address: 35.183.91.107
- Location: Montreal Canada
- Latitude: 45.4995
- Longitude: -73.5848
- Timezone: America/Toronto
- Postal: H3G
More informations about "Aspect Biosystems"
Our Story - Aspect Biosystems
We are a Canadian biotechnology company with a bold team of innovators & entrepreneurs from all over the globe. Bringing together different backgrounds, perspectives, and expertise …See details»
Get in Touch | Aspect Biosystems
Get in touch.. 887 Great Northern Way, #500 Vancouver BC, Canada V5T 4T5 +1 604 263 0502. General Inquiries. [email protected]; PR & Media Inquiries. [email protected]See details»
Aspect Biosystems - Crunchbase Company Profile
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease.See details»
Aspect Biosystems - LinkedIn
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases.See details»
From Research to Commercialization: The Aspect Biosystems …
Stem Cell Network, an organization focused on building Canada’s stem cell and regenerative medicine research sector. President & CEO Aspect Biosystems Aspect Biosystems is a …See details»
Aspect Biosystems Announces $200 Million Partnership …
Jul 10, 2024 The investment will support a $200 million, multi-year project to advance Aspect’s unique clinical biomanufacturing capabilities, full-stack tissue therapeutic platform, and pipeline of bioprinted tissue therapeutics.See details»
Aspect Biosystems, Author at Life Sciences British Columbia
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases.See details»
Aspect Biosystems – an Unreasonable company
Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics to transform how we treat disease.See details»
Aspect Biosystems Announces $200 Million Partnership with the ...
Jul 10, 2024 Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases.See details»
Aspect Biosystems Appoints Three New Board Members
Sep 21, 2022 Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics to transform how we treat disease.See details»
Aspect Biosystems Announces $200 Million Partnership with the ...
Jul 10, 2024 Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases.See details»
The National Research Council of Canada and Aspect Biosystems …
Feb 13, 2019 The National Research Council of Canada (NRC) is the Government of Canada’s largest research organization. It is a key part of the Innovation and Skills Plan and of Budget …See details»
Aspect Biosystems Appoints Three New Board Members
Sep 21, 2022 Aspect Biosystems is a biotechnology company creating bioprinted tissue therapeutics to transform how we treat disease.See details»
Aspect Biosystems Receives Over $3.6 Million From the …
Mar 20, 2023 Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases.See details»
Aspect Biosystems and JSR Corporation Enter ... - Business Wire
Mar 30, 2021 Learn more at www.aspectbiosystems ... JSR Corporation is a multinational company with research-oriented organization that pursues close collaborations with leading …See details»
Aspect Biosystems Partners With Merck, GSK, and McGill …
For more, visit www.aspectbiosystems.com. ... (CCS) is a national community-based organization whose mission is to eradicate cancer and improve the quality of life of people living with …See details»
Join our Team - Aspect Biosystems
Join our diverse team of innovators on our mission to transform how we treat disease with bioprinted tissue therapeutics.See details»
Aspect Biosystems Strengthens Expertise in Cell Therapy …
Aspect Biosystems is a biotechnology company creating bioprinted therapeutics as medicines of the future.See details»
Aspect Biosystems Receives Over $3.6 Million From the …
Mar 20, 2023 Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases.See details»